Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

European operators brace for second wave

COVID's second wave looks either imminent, or is already starting to hit in many jurisdictions. Wave one saw lockdowns and closures - and not all closures were temporary. Will wave two be any different? HBI has been talking to operators across EMEA to see if forewarned is forearmed, how they predict the next few months will go, and what lessons have been learned.

CMA price tag looks embarrassingly high

Potentially embarrassing details of the acquisition of CMA-Medina, the largest independent lab group in Belgium by French player Biogroup have emerged. Articles in the Belgian business press suggest massive gross margins and speculation that CMA sold for €1bn.

How Covid opens up new B2B and B2C testing markets

The lab sector could be "uberised" by an app which currently enables individuals to see where, and when they can get a Covid test as part of government and corporate schemes. The aim is to create a consumer solution which will enable individuals to select from a very wide range of tests on price and proximity.

Employee testing drives 30%+ organic growth for labs through summer

COVID-19 testing for businesses, the sports industry and governments has cancelled-out and countered most falls in routine testing for the pan-European lab groups. Synlab says it signed 3,000 back-to-work testing contracts and saw 32% y-o-y organic revenue growth in June while Eurofins has 1,200 signed or in discussion. HBI examines the impact of the pandemic so far and what's next.

Ada Health building diagnostic results into its app

In the peak of Germany's pandemic, symptom-checker app Ada Health rapidly built a solution to digitally return COVID-19 test results to a lab's customers. Founder Claire Novorol tells HBI that the new capability is part of a long term strategy that will allow the company to better incorporate diagnostic data into its app.

Sonic Healthcare ‘reviewing its Irish operations’

Global lab company Sonic Healthcare is reportedly reviewing its Irish operations as litigation claims related to Ireland’s CervicalCheck scandal mount and the subsidiary posts falling profits. HBI examines the role of the private sector in the screening scandal and talks to a solicitor representing half of the plaintiffs. Documents seen by HBI show evidence that slides were up to 7x more likely to be misread when outsourced.

BGI profits rocket but blacklisting could threaten supply chain

Profits at lab group Bejing Genomics Institute (BGI) are up 734% in the first half of the year after the company rapidly built 58 labs in 18 countries and sold 35m testing kits to 92% of the countries in the world for COVID-19. Yet the company is now caught up in the ever-escalating US-China trade war as two subsidiaries have been blacklisted by the States. HBI examines what this means for its global reach.

Find Us